Cargando…
The role of complement factor H in gestational diabetes mellitus and pregnancy
BACKGROUND: Complement factor H (CFH) has been found to be associated with insulin resistance. This study assessed the correlation between CFH and other clinical parameters, and determined whether CFH played a role in gestational diabetes mellitus (GDM) and adverse pregnancy outcomes. METHODS: A tot...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369714/ https://www.ncbi.nlm.nih.gov/pubmed/34404360 http://dx.doi.org/10.1186/s12884-021-04031-w |
_version_ | 1783739344796778496 |
---|---|
author | Li, Junxian Shen, Ying Tian, Hairong Xie, Shuting Ji, Ye Li, Ziyun Lu, Junxi Lu, Huijuan Liu, Bo Liu, Fang |
author_facet | Li, Junxian Shen, Ying Tian, Hairong Xie, Shuting Ji, Ye Li, Ziyun Lu, Junxi Lu, Huijuan Liu, Bo Liu, Fang |
author_sort | Li, Junxian |
collection | PubMed |
description | BACKGROUND: Complement factor H (CFH) has been found to be associated with insulin resistance. This study assessed the correlation between CFH and other clinical parameters, and determined whether CFH played a role in gestational diabetes mellitus (GDM) and adverse pregnancy outcomes. METHODS: A total of 397 pregnant women were included for analysis in this nested case-control study. Clinical parameters and serum were collected within the 11-17th gestational age at the first prenatal visit. At 24–28 weeks of gestation, a 75 g oral glucose tolerance test was performed and subjects were divided into a GDM (n = 80) and a non-GDM control group (n = 317). The delivery data were also followed. The serum CFH level was assayed by ELISA. RESULTS: CFH was higher in GDM than in non-GDM controls (280.02 [58.60] vs. 264.20 [68.77]; P = 0.014). CFH level was moderately associated with pre-pregnancy body mass index (BMI), BMI and total triglycerides (TG), and slightly associated with gestational age, low density lipoprotein cholesterol (LDL-C), total cholesterol (TC) in GDM and non-GDM (all P < 0.05). Moreover, CFH level was moderately correlated with alkaline phosphatase (ALP) and slightly correlated with age, uric acid (UA) and total bilirubin (TB) in non-GDM (all P < 0.05). After adjustment for clinical confounding factors, BMI, TG, gestational age, ALP, TB, age and UA were independent risk factors for log(10) CFH levels (all P < 0.05) in all subjects. In addition, overweight or obese pregnant women, women with hypertriglyceridemia and women in the second trimester had significantly higher CFH levels than normal weight and underweight group (P < 0.001), the non-hypertriglyceridemia group (P < 0.001) and women in the first trimester group (P < 0.05) in all pregnant women respectively. Following binary logistic regression, CFH was not independently associated with GDM and related pregnant outcomes. CONCLUSIONS: The CFH in 11-17th weeks of gestation might be affected by many factors, including BMI, TG, gestational age, ALP, TB, age and UA. CFH was not an independent risk factor for GDM and avderse pregnancy outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-021-04031-w. |
format | Online Article Text |
id | pubmed-8369714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83697142021-08-18 The role of complement factor H in gestational diabetes mellitus and pregnancy Li, Junxian Shen, Ying Tian, Hairong Xie, Shuting Ji, Ye Li, Ziyun Lu, Junxi Lu, Huijuan Liu, Bo Liu, Fang BMC Pregnancy Childbirth Research Article BACKGROUND: Complement factor H (CFH) has been found to be associated with insulin resistance. This study assessed the correlation between CFH and other clinical parameters, and determined whether CFH played a role in gestational diabetes mellitus (GDM) and adverse pregnancy outcomes. METHODS: A total of 397 pregnant women were included for analysis in this nested case-control study. Clinical parameters and serum were collected within the 11-17th gestational age at the first prenatal visit. At 24–28 weeks of gestation, a 75 g oral glucose tolerance test was performed and subjects were divided into a GDM (n = 80) and a non-GDM control group (n = 317). The delivery data were also followed. The serum CFH level was assayed by ELISA. RESULTS: CFH was higher in GDM than in non-GDM controls (280.02 [58.60] vs. 264.20 [68.77]; P = 0.014). CFH level was moderately associated with pre-pregnancy body mass index (BMI), BMI and total triglycerides (TG), and slightly associated with gestational age, low density lipoprotein cholesterol (LDL-C), total cholesterol (TC) in GDM and non-GDM (all P < 0.05). Moreover, CFH level was moderately correlated with alkaline phosphatase (ALP) and slightly correlated with age, uric acid (UA) and total bilirubin (TB) in non-GDM (all P < 0.05). After adjustment for clinical confounding factors, BMI, TG, gestational age, ALP, TB, age and UA were independent risk factors for log(10) CFH levels (all P < 0.05) in all subjects. In addition, overweight or obese pregnant women, women with hypertriglyceridemia and women in the second trimester had significantly higher CFH levels than normal weight and underweight group (P < 0.001), the non-hypertriglyceridemia group (P < 0.001) and women in the first trimester group (P < 0.05) in all pregnant women respectively. Following binary logistic regression, CFH was not independently associated with GDM and related pregnant outcomes. CONCLUSIONS: The CFH in 11-17th weeks of gestation might be affected by many factors, including BMI, TG, gestational age, ALP, TB, age and UA. CFH was not an independent risk factor for GDM and avderse pregnancy outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-021-04031-w. BioMed Central 2021-08-17 /pmc/articles/PMC8369714/ /pubmed/34404360 http://dx.doi.org/10.1186/s12884-021-04031-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Li, Junxian Shen, Ying Tian, Hairong Xie, Shuting Ji, Ye Li, Ziyun Lu, Junxi Lu, Huijuan Liu, Bo Liu, Fang The role of complement factor H in gestational diabetes mellitus and pregnancy |
title | The role of complement factor H in gestational diabetes mellitus and pregnancy |
title_full | The role of complement factor H in gestational diabetes mellitus and pregnancy |
title_fullStr | The role of complement factor H in gestational diabetes mellitus and pregnancy |
title_full_unstemmed | The role of complement factor H in gestational diabetes mellitus and pregnancy |
title_short | The role of complement factor H in gestational diabetes mellitus and pregnancy |
title_sort | role of complement factor h in gestational diabetes mellitus and pregnancy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369714/ https://www.ncbi.nlm.nih.gov/pubmed/34404360 http://dx.doi.org/10.1186/s12884-021-04031-w |
work_keys_str_mv | AT lijunxian theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT shenying theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT tianhairong theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT xieshuting theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT jiye theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT liziyun theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT lujunxi theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT luhuijuan theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT liubo theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT liufang theroleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT lijunxian roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT shenying roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT tianhairong roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT xieshuting roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT jiye roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT liziyun roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT lujunxi roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT luhuijuan roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT liubo roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy AT liufang roleofcomplementfactorhingestationaldiabetesmellitusandpregnancy |